Hyperlipoproteinemia Type
📧 Sign up to get email alerts when something new happens for Hyperlipoproteinemia Type.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-03EMA Authorised: Redemplo (plozasiran sodium) — Arrowhead Pharmaceuticals Ireland Limited
EMA has authorised Redemplo (plozasiran sodium) from Arrowhead Pharmaceuticals Ireland Limited for Hyperlipoproteinemia Type I.
-
EMA approval · 2026-03-23EMA Authorised: Waylivra (volanesorsen sodium) — Akcea Therapeutics Ireland Limited
The European Medicines Agency authorised Waylivra (volanesorsen) for Hyperlipoproteinemia Type I, under conditional approval with orphan des…
-
EMA approval · 2025-12-03EMA Authorised: Tryngolza (olezarsen sodium) — Swedish Orphan Biovitrum AB (publ)
The European Medicines Agency authorised Tryngolza (olezarsen sodium) from Swedish Orphan Biovitrum AB (publ) for hyperlipoproteinemia type …